Search research articles
Contact Us
Filters
Showing results (671-680 of 918) with videos related to
Page
of 92
Sort By:
The Journal of the Acoustical Society of America
|
May 4, 2020
Physical effects of sound exposure from underwater explosions on Pacific sardines (Sardinops sagax)
Peter H Dahl, A Keith Jenkins, Brandon Casper, et al.
Journal of Molecular Biology
|
November 22, 2011
Structural basis for activation of calcineurin by calmodulin
Julie Rumi-Masante, Farai I Rusinga, Terrence E Lester, et al.
Transplantation and Cellular Therapy
|
September 23, 2023
Continuous Elotuzumab, Pomalidomide, and Dexamethasone Maintenance Following Second Autologous Transplantation for Multiple Myeloma: Results of a Prospective Phase 2 Multicenter Trial
Michael Slade, Mark A Fiala, Marie Kirchmeyer, et al.
The Journal of Biological Chemistry
|
November 17, 2001
Protein-tyrosine phosphatase MEG2 is expressed by human neutrophils. Localization to the phagosome and activation by polyphosphoinositides
Joshua M Kruger, Takayasu Fukushima, Vera Cherepanov, et al.
European Journal of Haematology
|
May 19, 2010
Lenalidomide plus dexamethasone vs. lenalidomide plus melphalan and prednisone: a retrospective study in newly diagnosed elderly myeloma
Francesca Gay, S Vincent Rajkumar, Patrizia Falco, et al.
European Journal of Haematology
|
November 18, 2014
Phase 2 study of dovitinib in patients with relapsed or refractory multiple myeloma with or without t(4;14) translocation
Christof Scheid, Donna Reece, Meral Beksac, et al.
Trends in Biotechnology
|
August 1, 2006
Rational drug design via intrinsically disordered protein
Yugong Cheng, Tanguy LeGall, Christopher J Oldfield, et al.
Blood
|
December 20, 2008
Identification of a potent natural triterpenoid inhibitor of proteosome chymotrypsin-like activity and NF-kappaB with antimyeloma activity in vitro and in vivo
Rodger E Tiedemann, Jessica Schmidt, Jonathan J Keats, et al.
The Lancet. Oncology
|
June 6, 2018
Once weekly versus twice weekly carfilzomib dosing in patients with relapsed and refractory multiple myeloma (A.R.R.O.W.): interim analysis results of a randomised, phase 3 study
Philippe Moreau, Maria-Victoria Mateos, James R Berenson, et al.
American Journal of Respiratory Cell and Molecular Biology
|
September 3, 2002
Regulation of human Clara cell 10 kD protein expression by chicken ovalbumin upstream promoter transcription factors (COUP-TFs)
Roya Navab, Yimin Wang, Yu-Hua Chow, et al.
Page
of 92
Search research articles
Search
Showing results (671-680 of 918) with videos related to
Sort By:
Page
of 92
The Journal of the Acoustical Society of America
|
May 4, 2020
Physical effects of sound exposure from underwater explosions on Pacific sardines (Sardinops sagax)
Peter H Dahl, A Keith Jenkins, Brandon Casper, et al.
Journal of Molecular Biology
|
November 22, 2011
Structural basis for activation of calcineurin by calmodulin
Julie Rumi-Masante, Farai I Rusinga, Terrence E Lester, et al.
Transplantation and Cellular Therapy
|
September 23, 2023
Continuous Elotuzumab, Pomalidomide, and Dexamethasone Maintenance Following Second Autologous Transplantation for Multiple Myeloma: Results of a Prospective Phase 2 Multicenter Trial
Michael Slade, Mark A Fiala, Marie Kirchmeyer, et al.
The Journal of Biological Chemistry
|
November 17, 2001
Protein-tyrosine phosphatase MEG2 is expressed by human neutrophils. Localization to the phagosome and activation by polyphosphoinositides
Joshua M Kruger, Takayasu Fukushima, Vera Cherepanov, et al.
European Journal of Haematology
|
May 19, 2010
Lenalidomide plus dexamethasone vs. lenalidomide plus melphalan and prednisone: a retrospective study in newly diagnosed elderly myeloma
Francesca Gay, S Vincent Rajkumar, Patrizia Falco, et al.
European Journal of Haematology
|
November 18, 2014
Phase 2 study of dovitinib in patients with relapsed or refractory multiple myeloma with or without t(4;14) translocation
Christof Scheid, Donna Reece, Meral Beksac, et al.
Trends in Biotechnology
|
August 1, 2006
Rational drug design via intrinsically disordered protein
Yugong Cheng, Tanguy LeGall, Christopher J Oldfield, et al.
Blood
|
December 20, 2008
Identification of a potent natural triterpenoid inhibitor of proteosome chymotrypsin-like activity and NF-kappaB with antimyeloma activity in vitro and in vivo
Rodger E Tiedemann, Jessica Schmidt, Jonathan J Keats, et al.
The Lancet. Oncology
|
June 6, 2018
Once weekly versus twice weekly carfilzomib dosing in patients with relapsed and refractory multiple myeloma (A.R.R.O.W.): interim analysis results of a randomised, phase 3 study
Philippe Moreau, Maria-Victoria Mateos, James R Berenson, et al.
American Journal of Respiratory Cell and Molecular Biology
|
September 3, 2002
Regulation of human Clara cell 10 kD protein expression by chicken ovalbumin upstream promoter transcription factors (COUP-TFs)
Roya Navab, Yimin Wang, Yu-Hua Chow, et al.
Page
of 92